Reading view
Yuan3.0 Flash: An Open Multimodal Large Language Model for Enterprise Applications
XAI-MeD: Explainable Knowledge Guided Neuro-Symbolic Framework for Domain Generalization and Rare Class Detection in Medical Imaging
MACA: A Framework for Distilling Trustworthy LLMs into Efficient Retrievers
Digital Twin-Driven Communication-Efficient Federated Anomaly Detection for Industrial IoT
How to make Medical AI Systems safer? Simulating Vulnerabilities, and Threats in Multimodal Medical RAG System
Wearable-informed generative digital avatars predict task-conditioned post-stroke locomotion
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
Nature Medicine, Published online: 05 January 2026; doi:10.1038/s41591-025-04080-0
This multicenter study demonstrates use of dried and capillary blood as a minimally invasive, scalable approach for Alzheimer’s biomarker testing in research, with potential as a widely scalable population-based research approach, especially in resource-limited settings.Digital Twin based Automatic Reconfiguration of Robotic Systems in Smart Environments
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial
Nature Medicine, Published online: 02 January 2026; doi:10.1038/s41591-025-04043-5
Results of the phase 1/2 TACTOPS trial show that autologous T cell therapy targeting PRAME, SSX2, MAGEA4, Survivin and NY-ESO-1 in patients with pancreatic ductal adenocarcinoma is feasible and safe, and leads to encouraging clinical responses and evidence of antigen spreading in responders.DarkPatterns-LLM: A Multi-Layer Benchmark for Detecting Manipulative and Harmful AI Behavior
Why AI Safety Requires Uncertainty, Incomplete Preferences, and Non-Archimedean Utilities
Interpretable Link Prediction in AI-Driven Cancer Research: Uncovering Co-Authorship Patterns
LLM-Guided Exemplar Selection for Few-Shot Wearable-Sensor Human Activity Recognition
MedGemma vs GPT-4: Open-Source and Proprietary Zero-shot Medical Disease Classification from Images
Generating Verifiable Chain of Thoughts from Exection-Traces
Modeling hepatocellular carcinoma and its microenvironment on a chip
Cell Death Discovery, Published online: 29 December 2025; doi:10.1038/s41420-025-02917-8
Modeling hepatocellular carcinoma and its microenvironment on a chipMetabolic signatures in gastroenteropancreatic neuroendocrine neoplasms: unraveling diagnostic and prognostic insights
Front Endocrinol (Lausanne). 2025 Dec 11;16:1676021. doi: 10.3389/fendo.2025.1676021. eCollection 2025.
ABSTRACT
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of tumors characterized by diverse biological behaviors and variable clinical outcomes. Recent advances have highlighted the important role of metabolic reprogramming in tumorigenesis, progression, and therapeutic resistance in GEP-NENs. In this review, we synthesize the current evidence on metabolic biomarkers and altered metabolic pathways-particularly those involving glucose, lipid, and amino acid metabolism. Key biomarkers such as GLUT-1, FASN, and enzymes involved in ferroptosis, cholesterol biosynthesis, and amino acid catabolism demonstrate strong associations with tumor aggressiveness, hypoxia, and mTOR signaling. Moreover, metabolomic profiling and functional studies suggest that metabolic markers may inform prognosis and predict response to targeted therapies such as Everolimus. Although promising, the clinical translation of these markers is still limited and requires further validation in large, subtype-specific cohorts. Our findings highlight the importance of integrating metabolic profiling into the diagnostic and therapeutic landscape of GEP-NENs. Future research should prioritize biomarker standardization, multi-omics integration, and the development of metabolism-based therapeutic strategies tailored to tumor subtype and differentiation grade.
PMID:41458541 | PMC:PMC12738315 | DOI:10.3389/fendo.2025.1676021